IMI2: Nabór wniosków w kolejne edycji konkursu
Do 28 lutego 2018 r. trwa nabór wniosków w ramach 13. edycji konkursu w ramach Inicjatywy Leków Innowacyjnych 2. Nabór wniosków prowadzony jest w 15 tematach. Budżet konkursu wynosi ponad 106 mln euro.
Zgodnie z informacjami organizatorów nabór wniosków prowadzony jest w następujących tematach:
Topic 1: Assessment of the uniqueness of diabetic cardiomyopathy relative to other forms of heart failure using unbiased pheno-mapping approaches
Topic 2: Genome-Environment Interactions in Inflammatory Skin Disease
Topic 3: The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use
Topic 4: Mitochondrial Dysfunction in Neurodegeneration
Topic 5: Support and coordination action for the projects in the neurodegeneration area of the Innovative Medicines Initiative
Topic 6: A sustainable European induced pluripotent stem cell platform
Topic 7: Linking digital assessment of mobility to clinical endpoints to support regulatory acceptance and clinical practice
Topic 8: Human tumour microenvironment immunoprofiling
Topic 9: ConcePTION – Continuum of Evidence from Pregnancy Exposures, Reproductive Toxicology and Breastfeeding to Improve Outcomes Now
Topic 10: Improving the preclinical prediction of adverse effects of pharmaceuticals on the nervous system
Topic 11: Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease
Topic 12: Pilot programme on a Clinical Compound Bank for Repurposing: Cardiovascular diseases and diabetes
Topic 13: Pilot programme on a Clinical Compound Bank for Repurposing: Respiratory diseases
Topic 14: Pilot programme on a Clinical Compound Bank for Repurposing: Neurodegenerative diseases
Topic 15: Pilot programme on a Clinical Compound Bank for Repurposing: Rare/orphan diseases
Szczegółowe informacje o konkursie można znaleźć na stronie internetowej www.imi.europa.eu.
Zgodnie z informacjami organizatorów nabór wniosków prowadzony jest w następujących tematach:
Topic 1: Assessment of the uniqueness of diabetic cardiomyopathy relative to other forms of heart failure using unbiased pheno-mapping approaches
Topic 2: Genome-Environment Interactions in Inflammatory Skin Disease
Topic 3: The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use
Topic 4: Mitochondrial Dysfunction in Neurodegeneration
Topic 5: Support and coordination action for the projects in the neurodegeneration area of the Innovative Medicines Initiative
Topic 6: A sustainable European induced pluripotent stem cell platform
Topic 7: Linking digital assessment of mobility to clinical endpoints to support regulatory acceptance and clinical practice
Topic 8: Human tumour microenvironment immunoprofiling
Topic 9: ConcePTION – Continuum of Evidence from Pregnancy Exposures, Reproductive Toxicology and Breastfeeding to Improve Outcomes Now
Topic 10: Improving the preclinical prediction of adverse effects of pharmaceuticals on the nervous system
Topic 11: Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease
Topic 12: Pilot programme on a Clinical Compound Bank for Repurposing: Cardiovascular diseases and diabetes
Topic 13: Pilot programme on a Clinical Compound Bank for Repurposing: Respiratory diseases
Topic 14: Pilot programme on a Clinical Compound Bank for Repurposing: Neurodegenerative diseases
Topic 15: Pilot programme on a Clinical Compound Bank for Repurposing: Rare/orphan diseases
Szczegółowe informacje o konkursie można znaleźć na stronie internetowej www.imi.europa.eu.
Źródło: www.granty-na-badania.com
wstecz Podziel się ze znajomymi
03-03-2023
Najdokładniejsze systemy satelitarnego transferu czasu
Nie zawsze zegar atomowy działa lepiej niż kwarcowy.
03-03-2023
Ponad połowa chorych z SARS-CoV2 cierpi na długi covid
Przez długi czas może mieć takie objawy jak zmęczenie.
03-03-2023
Uniwersytet Warszawski będzie kształcić kadry dla energetyki jądrowej
Przekazał Wydział Fizyki UW.
Recenzje